Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence for the Analysis of STAS and Lung Cancer Risk Stratification

NCT07617636 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07617636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07617636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence for the Analysis of STAS and Lung Cancer Risk Stratification
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
August 31, 2027
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer